Innovation Active Updated Jul 29, 2026
Rhiza mycoprotein's market-by-market rollout
BMC Ingredients is clearing its whole-food mycelium protein Rhiza through one national regulator after another, from the US FDA and Singapore in 2024 to Health Canada in July 2026, while working toward price parity with commodity beef at a not yet built commercial facility. The storyline tracks which markets clear next and whether the company's unaudited price-parity claim holds once production scales.
The story so far
-
Jul 29, 2026 Latest
Health Canada cleared BMC Ingredients' Rhiza mycoprotein for sale, the company's third regulatory market after the US FDA and Singapore in 2024. CEO Paul Shapiro said BMC is targeting a 2027 launch once its new production facility comes online and projects reaching price parity with wholesale commodity beef once fully commercialized there.
Get the next update to this storyline by email.
When this fight moves, the new beat lands on this timeline and in the morning brief the same day. Follow it free, and you will know before the feeds do.
Free, every morning. Unsubscribe in one click.